Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new 'Locations' section appears listing Michigan and New York sites; the separate 'Michigan Locations' and 'New York Locations' entries were removed, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.0%

- Check37 days agoChange DetectedThe notice about government funding and NIH operating status has been removed from the page.SummaryDifference0.3%

- Check59 days agoChange DetectedMinor UI adjustments and potential timestamp changes were observed on the page; there are no alterations to core study details or purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedAdds new organizational/time context and expands IPD data sharing details while removing the previous sharing URLs and streamlined criteria.SummaryDifference11%

- Check80 days agoChange DetectedThe page now communicates an operating-status notice and that the NIH Clinical Center is open, along with where to verify status, and it updates the version from v3.1.0 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.